Published in PLoS One on October 26, 2011
The pathophysiology of fragile X (and what it teaches us about synapses). Annu Rev Neurosci (2012) 2.16
Fragile X syndrome: causes, diagnosis, mechanisms, and therapeutics. J Clin Invest (2012) 1.42
Progress toward treatments for synaptic defects in autism. Nat Med (2013) 1.24
Fragile X mental retardation protein and synaptic plasticity. Mol Brain (2013) 1.12
Outcome measures for clinical trials in fragile X syndrome. J Dev Behav Pediatr (2013) 1.10
Down syndrome: the brain in trisomic mode. Nat Rev Neurosci (2012) 1.10
Genetic manipulation of STEP reverses behavioral abnormalities in a fragile X syndrome mouse model. Genes Brain Behav (2012) 1.08
Identification of fragile X syndrome specific molecular markers in human fibroblasts: a useful model to test the efficacy of therapeutic drugs. Hum Mutat (2014) 0.95
Dysregulation and restoration of translational homeostasis in fragile X syndrome. Nat Rev Neurosci (2015) 0.91
Therapeutic Strategies in Fragile X Syndrome: From Bench to Bedside and Back. Neurotherapeutics (2015) 0.90
Abnormal intracellular accumulation and extracellular Aβ deposition in idiopathic and Dup15q11.2-q13 autism spectrum disorders. PLoS One (2012) 0.89
Neuronal nucleus and cytoplasm volume deficit in children with autism and volume increase in adolescents and adults. Acta Neuropathol Commun (2015) 0.87
Antipurinergic therapy corrects the autism-like features in the Fragile X (Fmr1 knockout) mouse model. Mol Autism (2015) 0.87
Learning and behavioral deficits associated with the absence of the fragile X mental retardation protein: what a fly and mouse model can teach us. Learn Mem (2014) 0.85
Emerging pharmacologic treatment options for fragile X syndrome. Appl Clin Genet (2015) 0.84
Targeted pharmacological treatment of autism spectrum disorders: fragile X and Rett syndromes. Front Cell Neurosci (2015) 0.84
Metabotropic glutamate receptor 5 knockout reduces cognitive impairment and pathogenesis in a mouse model of Alzheimer's disease. Mol Brain (2014) 0.84
Soy-based diet exacerbates seizures in mouse models of neurological disease. J Alzheimers Dis (2013) 0.83
Transgene expression in the Nop-tTA driver line is not inherently restricted to the entorhinal cortex. Brain Struct Funct (2015) 0.82
Impact of acamprosate on plasma amyloid-β precursor protein in youth: a pilot analysis in fragile X syndrome-associated and idiopathic autism spectrum disorder suggests a pharmacodynamic protein marker. J Psychiatr Res (2014) 0.82
Long-term Continuous EEG Monitoring in Small Rodent Models of Human Disease Using the Epoch Wireless Transmitter System. J Vis Exp (2015) 0.82
Increasing our understanding of human cognition through the study of Fragile X Syndrome. Dev Neurobiol (2013) 0.82
The regulation of AβPP expression by RNA-binding proteins. Ageing Res Rev (2012) 0.81
Fluorescent labeling of dendritic spines in cell cultures with the carbocyanine dye "DiI". Front Neuroanat (2014) 0.81
Fragile X mental retardation protein: from autism to neurodegenerative disease. Front Cell Neurosci (2015) 0.80
From FMRP function to potential therapies for fragile X syndrome. Neurochem Res (2013) 0.80
Dendrite and spine modifications in autism and related neurodevelopmental disorders in patients and animal models. Dev Neurobiol (2016) 0.80
Persistent astrocyte activation in the fragile X mouse cerebellum. Brain Behav (2015) 0.79
Finding novel distinctions between the sAPPα-mediated anabolic biochemical pathways in Autism Spectrum Disorder and Fragile X Syndrome plasma and brain tissue. Sci Rep (2016) 0.79
Novel roles of amyloid-beta precursor protein metabolites in fragile X syndrome and autism. Mol Psychiatry (2016) 0.79
Developing BACE-1 inhibitors for FXS. Front Cell Neurosci (2013) 0.78
A common STEP in the synaptic pathology of diverse neuropsychiatric disorders. Yale J Biol Med (2012) 0.78
Fragile X mental retardation protein expression in Alzheimer's disease. Front Genet (2014) 0.78
Multiple Drug Treatments That Increase cAMP Signaling Restore Long-Term Memory and Aberrant Signaling in Fragile X Syndrome Models. Front Behav Neurosci (2016) 0.76
Alzheimer-related decrease in CYFIP2 links amyloid production to tau hyperphosphorylation and memory loss. Brain (2016) 0.76
Commentary: Depletion of the Fragile X Mental Retardation Protein in Embryonic Stem Cells Alters the Kinetics of Neurogenesis. Front Mol Neurosci (2017) 0.75
Early-Onset Network Hyperexcitability in Presymptomatic Alzheimer's Disease Transgenic Mice Is Suppressed by Passive Immunization with Anti-Human APP/Aβ Antibody and by mGluR5 Blockade. Front Aging Neurosci (2017) 0.75
APP Causes Hyperexcitability in Fragile X Mice. Front Mol Neurosci (2016) 0.75
Astrocyte-secreted thrombospondin-1 modulates synapse and spine defects in the fragile X mouse model. Mol Brain (2016) 0.75
A hypothesis regarding the molecular mechanism underlying dietary soy-induced effects on seizure propensity. Front Neurol (2014) 0.75
The quest for fragile X biomarkers. Mol Cell Pediatr (2014) 0.75
Molecular systems evaluation of oligomerogenic APP(E693Q) and fibrillogenic APP(KM670/671NL)/PSEN1(Δexon9) mouse models identifies shared features with human Alzheimer's brain molecular pathology. Mol Psychiatry (2015) 0.75
Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature (2002) 19.36
Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med (2008) 17.09
Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell (1991) 17.00
Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci U S A (1985) 16.10
Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci U S A (1998) 16.04
The mGluR theory of fragile X mental retardation. Trends Neurosci (2004) 8.88
APP processing and synaptic function. Neuron (2003) 8.37
Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome. Cell (2001) 8.04
Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science (1991) 7.16
Correction of fragile X syndrome in mice. Neuron (2007) 6.51
Altered synaptic plasticity in a mouse model of fragile X mental retardation. Proc Natl Acad Sci U S A (2002) 6.45
Role for rapid dendritic protein synthesis in hippocampal mGluR-dependent long-term depression. Science (2000) 5.28
Synaptic targeting by Alzheimer's-related amyloid beta oligomers. J Neurosci (2004) 5.10
Plasma Abeta(1-40) and Abeta(1-42) and the risk of dementia: a prospective case-cohort study. Lancet Neurol (2006) 4.77
Fmr1 knockout mice: a model to study fragile X mental retardation. The Dutch-Belgian Fragile X Consortium. Cell (1994) 4.43
The fragile X syndrome protein FMRP associates with BC1 RNA and regulates the translation of specific mRNAs at synapses. Cell (2003) 4.34
Pharmacological rescue of synaptic plasticity, courtship behavior, and mushroom body defects in a Drosophila model of fragile X syndrome. Neuron (2005) 4.11
Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP. Neuropharmacology (2005) 4.09
Soluble oligomers of amyloid Beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake. Neuron (2009) 3.94
Evidence that fragile X mental retardation protein is a negative regulator of translation. Hum Mol Genet (2001) 3.91
Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains. J Biol Chem (1996) 3.84
Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann Neurol (1985) 3.83
Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-X syndrome: a quantitative examination. Am J Med Genet (2001) 3.77
Dendritic anomalies in disorders associated with mental retardation. Cereb Cortex (2000) 3.69
RNA cargoes associating with FMRP reveal deficits in cellular functioning in Fmr1 null mice. Neuron (2003) 3.58
Biochemical markers in persons with preclinical familial Alzheimer disease. Neurology (2008) 3.54
From mRNP trafficking to spine dysmorphogenesis: the roots of fragile X syndrome. Nat Rev Neurosci (2005) 3.46
beta-Amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity. Cell (1995) 3.33
Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease. Arch Neurol (2007) 3.25
The fragile X mental retardation protein inhibits translation via interacting with mRNA. Nucleic Acids Res (2001) 3.18
Trapping of messenger RNA by Fragile X Mental Retardation protein into cytoplasmic granules induces translation repression. Hum Mol Genet (2002) 3.17
Soluble oligomers of beta amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus. Brain Res (2002) 2.88
Marble burying reflects a repetitive and perseverative behavior more than novelty-induced anxiety. Psychopharmacology (Berl) (2009) 2.76
FMRP mediates mGluR5-dependent translation of amyloid precursor protein. PLoS Biol (2007) 2.75
Analysis of neocortex in three males with the fragile X syndrome. Am J Med Genet (1991) 2.70
Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses. Neurobiol Dis (2005) 2.70
Plasma and cerebrospinal fluid levels of amyloid beta proteins 1-40 and 1-42 in Alzheimer disease. Arch Neurol (2000) 2.66
Rescue of behavioral phenotype and neuronal protrusion morphology in Fmr1 KO mice. Neurobiol Dis (2008) 2.52
Evaluation of plasma Abeta(40) and Abeta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment. Neurobiol Aging (2008) 2.51
Plasma A[beta]40 and A[beta]42 and Alzheimer's disease: relation to age, mortality, and risk. Neurology (2003) 2.44
Deleterious effects of amyloid beta oligomers acting as an extracellular scaffold for mGluR5. Neuron (2010) 2.34
The fragile X protein controls microtubule-associated protein 1B translation and microtubule stability in brain neuron development. Proc Natl Acad Sci U S A (2004) 2.34
Fragile X mice develop sensory hyperreactivity to auditory stimuli. Neuroscience (2001) 2.31
Autism spectrum phenotype in males and females with fragile X full mutation and premutation. J Autism Dev Disord (2007) 2.28
Electrodermal responses to sensory stimuli in individuals with fragile X syndrome: a preliminary report. Am J Med Genet (1999) 2.26
Critical periods during sensory development. Curr Opin Neurobiol (2000) 2.20
Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model. J Med Genet (2008) 2.20
Fenobam: a clinically validated nonbenzodiazepine anxiolytic is a potent, selective, and noncompetitive mGlu5 receptor antagonist with inverse agonist activity. J Pharmacol Exp Ther (2005) 2.08
Role for metabotropic glutamate receptor 5 (mGluR5) in the pathogenesis of fragile X syndrome. J Physiol (2008) 2.08
Sensorimotor gating abnormalities in young males with fragile X syndrome and Fmr1-knockout mice. Mol Psychiatry (2004) 2.00
The Drosophila beta-amyloid precursor protein homolog promotes synapse differentiation at the neuromuscular junction. J Neurosci (1999) 1.90
Local functions for FMRP in axon growth cone motility and activity-dependent regulation of filopodia and spine synapses. Mol Cell Neurosci (2006) 1.88
Peripheral Abeta subspecies as risk biomarkers of Alzheimer's disease. Proc Natl Acad Sci U S A (2008) 1.84
Adult fragile X syndrome. Clinico-neuropathologic findings. Acta Neuropathol (1985) 1.80
Epilepsy in fragile X syndrome. Dev Med Child Neurol (2002) 1.66
Synaptotrophic effects of human amyloid beta protein precursors in the cortex of transgenic mice. Brain Res (1994) 1.58
A phenotypic and molecular characterization of the fmr1-tm1Cgr fragile X mouse. Genes Brain Behav (2004) 1.52
The Fra(X) syndrome: neurological, electrophysiological, and neuropathological abnormalities. Am J Med Genet (1991) 1.46
Epilepsy and EEG findings in males with fragile X syndrome. Epilepsia (1999) 1.42
Beta-amyloid precursor protein isoforms in various rat brain regions and during brain development. J Neurochem (1992) 1.27
Molecular-clinical correlations in males with an expanded FMR1 mutation. Am J Med Genet (1996) 1.24
Plasma levels of amyloid beta-protein 42 are increased in women with mild cognitive impairment. Neurology (2004) 1.23
Minocycline inhibits neuronal death and glial activation induced by beta-amyloid peptide in rat hippocampus. Glia (2004) 1.21
The amyloid precursor protein is developmentally regulated and correlated with synaptogenesis. Dev Biol (1994) 1.19
Elevated plasma beta-amyloid peptide Abeta(42) levels, incident dementia, and mortality in Down syndrome. Arch Neurol (2007) 1.19
High levels of Alzheimer beta-amyloid precursor protein (APP) in children with severely autistic behavior and aggression. J Child Neurol (2006) 1.18
Increased expression of beta-amyloid precursor protein during neuronal differentiation is not accompanied by secretory cleavage. Proc Natl Acad Sci U S A (1992) 1.15
A null mutation for Fmr1 in female mice: effects on regional cerebral metabolic rate for glucose and relationship to behavior. Neuroscience (2005) 1.15
Regulation of nuclear factor kappaB in the hippocampus by group I metabotropic glutamate receptors. J Neurosci (2006) 1.08
Mechanism of membrane depolarization caused by the Alzheimer Abeta1-42 peptide. Biochem Biophys Res Commun (2002) 1.07
Comorbidity of autistic spectrum disorders in children with Down syndrome. Dev Med Child Neurol (1999) 1.01
MAPK recruitment by beta-amyloid in organotypic hippocampal slice cultures depends on physical state and exposure time. J Neurochem (2004) 0.99
Amyloid precursor protein is localized in growing neurites of neonatal rat brain. Brain Res (1992) 0.98
Extracellular-regulated kinase controls beta-amyloid precursor protein mRNA decay. Brain Res Mol Brain Res (2001) 0.98
Peripheral biomarkers in Autism: secreted amyloid precursor protein-alpha as a probable key player in early diagnosis. Int J Clin Exp Med (2008) 0.98
Increased amyloid beta protein levels in children and adolescents with Down syndrome. J Neurol Sci (2007) 0.97
Fragile X syndrome and selective mutism. Am J Med Genet (1999) 0.97
Plasma levels of alpha beta peptides are altered in amnestic mild cognitive impairment but not in sporadic Alzheimer's disease. Acta Neurobiol Exp (Wars) (2005) 0.96
Gene expression profiles in a transgenic animal model of fragile X syndrome. Neurobiol Dis (2002) 0.96
Regulation and expression of the Alzheimer's beta/A4 amyloid protein precursor in health, disease, and Down's syndrome. Ann N Y Acad Sci (1993) 0.95
Phenyl ureas of creatinine as mGluR5 antagonists. A structure-activity relationship study of fenobam analogues. Bioorg Med Chem Lett (2005) 0.95
Early-phase ERK activation as a biomarker for metabolic status in fragile X syndrome. Am J Med Genet B Neuropsychiatr Genet (2008) 0.95
Demonstration of abnormal cyclic AMP production in platelets from patients with fragile X syndrome. Am J Med Genet (1993) 0.93
Inhibitory effect of minocycline on amyloid beta fibril formation and human microglial activation. Glia (2006) 0.92
Abeta promotes Alzheimer's disease-like cytoskeleton abnormalities with consequences to APP processing in neurons. J Neurochem (2010) 0.91
Alzheimer's disease and Down syndrome rodent models exhibit audiogenic seizures. J Alzheimers Dis (2010) 0.90
NADPH oxidase mediates beta-amyloid peptide-induced activation of ERK in hippocampal organotypic cultures. Mol Brain (2009) 0.83
beta-Amyloid1-40 increases expression of beta-amyloid precursor protein in neuronal hybrid cells. J Neurochem (1995) 0.78
Regulation of histone acetylation during memory formation in the hippocampus. J Biol Chem (2004) 5.99
Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system. J Neurosci (2002) 3.12
Advances in the treatment of fragile X syndrome. Pediatrics (2009) 3.10
The fragile X mental retardation protein is required for type-I metabotropic glutamate receptor-dependent translation of PSD-95. Proc Natl Acad Sci U S A (2003) 2.82
FMRP mediates mGluR5-dependent translation of amyloid precursor protein. PLoS Biol (2007) 2.75
Fragile X premutation carriers: characteristic MR imaging findings of adult male patients with progressive cerebellar and cognitive dysfunction. AJNR Am J Neuroradiol (2002) 2.58
Circulating anti-wild-type adeno-associated virus type 2 (AAV2) antibodies inhibit recombinant AAV2 (rAAV2)-mediated, but not rAAV5-mediated, gene transfer in the brain. J Virol (2004) 2.12
ERK/MAPK regulates hippocampal histone phosphorylation following contextual fear conditioning. Learn Mem (2006) 2.08
An official ATS clinical policy statement: Congenital central hypoventilation syndrome: genetic basis, diagnosis, and management. Am J Respir Crit Care Med (2010) 2.07
Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study. Blood (2008) 2.00
The peptidyl-prolyl isomerase Pin1 regulates the stability of granulocyte-macrophage colony-stimulating factor mRNA in activated eosinophils. Nat Immunol (2005) 1.99
Nigrostriatal alpha-synucleinopathy induced by viral vector-mediated overexpression of human alpha-synuclein: a new primate model of Parkinson's disease. Proc Natl Acad Sci U S A (2003) 1.92
Genetics of congenital central hypoventilation syndrome: lessons from a seemingly orphan disease. Am J Respir Crit Care Med (2004) 1.81
Congenital central hypoventilation syndrome: PHOX2B genotype determines risk for sudden death. Pediatr Pulmonol (2008) 1.75
Idiopathic congenital central hypoventilation syndrome: analysis of genes pertinent to early autonomic nervous system embryologic development and identification of mutations in PHOX2b. Am J Med Genet A (2003) 1.74
Recombinant adeno-associated viral vector (rAAV) delivery of GDNF provides protection against 6-OHDA lesion in the common marmoset monkey (Callithrix jacchus). Exp Neurol (2003) 1.72
The prolyl isomerase Pin1 acts as a novel molecular switch for TNF-alpha-induced priming of the NADPH oxidase in human neutrophils. Blood (2010) 1.68
CGG repeat length correlates with age of onset of motor signs of the fragile X-associated tremor/ataxia syndrome (FXTAS). Am J Med Genet B Neuropsychiatr Genet (2007) 1.66
Sudden infant death syndrome: case-control frequency differences at genes pertinent to early autonomic nervous system embryologic development. Pediatr Res (2004) 1.64
Rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation presenting in childhood. Pediatrics (2007) 1.60
Open-label add-on treatment trial of minocycline in fragile X syndrome. BMC Neurol (2010) 1.59
A critical role for Pin1 in allergic pulmonary eosinophilia in rats. J Allergy Clin Immunol (2007) 1.58
Significant association of multiple human cytomegalovirus genomic Loci with glioblastoma multiforme samples. J Virol (2011) 1.56
Recombinant adeno-associated viral vectors as therapeutic agents to treat neurological disorders. Mol Ther (2006) 1.54
Reduced juvenile long-term depression in tuberous sclerosis complex is mitigated in adults by compensatory recruitment of mGluR5 and Erk signaling. PLoS Biol (2013) 1.47
Long-term consequences of human alpha-synuclein overexpression in the primate ventral midbrain. Brain (2007) 1.45
Widespread non-central nervous system organ pathology in fragile X premutation carriers with fragile X-associated tremor/ataxia syndrome and CGG knock-in mice. Acta Neuropathol (2011) 1.39
beta-Amyloid degradation and Alzheimer's disease. J Biomed Biotechnol (2006) 1.35
Therapeutic strategies in fragile X syndrome: dysregulated mGluR signaling and beyond. Neuropsychopharmacology (2011) 1.30
The peptidyl-prolyl isomerase Pin1 facilitates cytokine-induced survival of eosinophils by suppressing Bax activation. Nat Immunol (2009) 1.29
Pin1 regulates TGF-beta1 production by activated human and murine eosinophils and contributes to allergic lung fibrosis. J Clin Invest (2008) 1.28
Rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation: analysis of hypothalamic and autonomic candidate genes. Pediatr Res (2011) 1.28
Metabolic regulation of neuronal plasticity by the energy sensor AMPK. PLoS One (2010) 1.25
Sudden Infant Death Syndrome: review of implicated genetic factors. Am J Med Genet A (2007) 1.19
Clinical trials in neurological disorders using AAV vectors: promises and challenges. Curr Opin Mol Ther (2004) 1.16
Patterns of gene expression reveal a temporally orchestrated wound healing response in the injured spinal cord. J Neurosci (2004) 1.13
Fibroblast phenotype in male carriers of FMR1 premutation alleles. Hum Mol Genet (2009) 1.11
Altered longevity-assurance activity of p53:p44 in the mouse causes memory loss, neurodegeneration and premature death. Aging Cell (2010) 1.11
The peptidyl-prolyl isomerase Pin1 regulates granulocyte-macrophage colony-stimulating factor mRNA stability in T lymphocytes. J Immunol (2006) 1.07
Tight Long-term dynamic doxycycline responsive nigrostriatal GDNF using a single rAAV vector. Mol Ther (2009) 1.07
rAAV-mediated nigral human parkin over-expression partially ameliorates motor deficits via enhanced dopamine neurotransmission in a rat model of Parkinson's disease. Exp Neurol (2007) 1.05
Reversal of motor impairments in parkinsonian rats by continuous intrastriatal delivery of L-dopa using rAAV-mediated gene transfer. Proc Natl Acad Sci U S A (2002) 1.04
Differential expression of 2',3'-cyclic-nucleotide 3'-phosphodiesterase and neural lineage markers correlate with glioblastoma xenograft infiltration and patient survival. Clin Cancer Res (2012) 1.03
Congenital central hypoventilation syndrome from past to future: model for translational and transitional autonomic medicine. Pediatr Pulmonol (2009) 1.02
Sudden infant death syndrome: association with a promoter polymorphism of the serotonin transporter gene. Am J Med Genet A (2003) 1.02
Pin1 and PKMzeta sequentially control dendritic protein synthesis. Sci Signal (2010) 1.00
Striatal readministration of rAAV vectors reveals an immune response against AAV2 capsids that can be circumvented. Mol Ther (2009) 1.00
Increased angiogenesis and angiogenic gene expression in carotid artery plaques from symptomatic stroke patients. Neurosurgery (2006) 1.00
Seizure susceptibility and mortality in mice that over-express amyloid precursor protein. Int J Clin Exp Pathol (2008) 1.00
RhoB mRNA is stabilized by HuR after UV light. Oncogene (2005) 0.99
MAPK recruitment by beta-amyloid in organotypic hippocampal slice cultures depends on physical state and exposure time. J Neurochem (2004) 0.99
Expression of interleukin-5- and granulocyte macrophage-colony-stimulating factor-responsive genes in blood and airway eosinophils. Am J Respir Cell Mol Biol (2003) 0.98
Comparison of PHOX2B testing methods in the diagnosis of congenital central hypoventilation syndrome and mosaic carriers. Diagn Mol Pathol (2010) 0.98
PHOX2B mutation-confirmed congenital central hypoventilation syndrome: presentation in adulthood. Am J Respir Crit Care Med (2006) 0.98
Decoy mRNAs reduce beta-amyloid precursor protein mRNA in neuronal cells. Neurobiol Aging (2006) 0.97
Rescue of synaptic plasticity and spatial learning deficits in the hippocampus of Homer1 knockout mice by recombinant Adeno-associated viral gene delivery of Homer1c. Neurobiol Learn Mem (2011) 0.97
Hypothalamic rAAV-mediated GDNF gene delivery ameliorates age-related obesity. Neurobiol Aging (2005) 0.97
Viral delivery of glial cell line-derived neurotrophic factor improves behavior and protects striatal neurons in a mouse model of Huntington's disease. Proc Natl Acad Sci U S A (2006) 0.96
Association of the serotonin transporter gene with sudden infant death syndrome: a haplotype analysis. Am J Med Genet A (2003) 0.95
Adult identified with congenital central hypoventilation syndrome--mutation in PHOX2b gene and late-onset CHS. Am J Respir Crit Care Med (2005) 0.95
Pin1 modulates the type 1 immune response. PLoS One (2007) 0.95
Mixed-lineage kinase 3 phosphorylates prolyl-isomerase Pin1 to regulate its nuclear translocation and cellular function. Proc Natl Acad Sci U S A (2012) 0.94
Whisker stimulation-dependent translation of FMRP in the barrel cortex requires activation of type I metabotropic glutamate receptors. Brain Res Mol Brain Res (2003) 0.93
Nurr1 regulates RET expression in dopamine neurons of adult rat midbrain. J Neurochem (2010) 0.93
T cell-derived interleukin (IL)-21 promotes brain injury following stroke in mice. J Exp Med (2014) 0.93
In pursuit (and discovery) of a genetic basis for congenital central hypoventilation syndrome. Respir Physiol Neurobiol (2005) 0.92
Congenital central hypoventilation syndrome (CCHS) and sudden infant death syndrome (SIDS): kindred disorders of autonomic regulation. Respir Physiol Neurobiol (2008) 0.91
Tissue transglutaminase, protein cross-linking and Alzheimer's disease: review and views. Int J Clin Exp Pathol (2008) 0.90
Alzheimer's disease and Down syndrome rodent models exhibit audiogenic seizures. J Alzheimers Dis (2010) 0.90
Identification of genes expressed by human airway eosinophils after an in vivo allergen challenge. PLoS One (2013) 0.90
Therapeutic Strategies in Fragile X Syndrome: From Bench to Bedside and Back. Neurotherapeutics (2015) 0.90
Reversal of dyskinesias in an animal model of Parkinson's disease by continuous L-DOPA delivery using rAAV vectors. Brain (2005) 0.89
Pinning down signaling in the immune system: the role of the peptidyl-prolyl isomerase Pin1 in immune cell function. Crit Rev Immunol (2008) 0.89
Ets-1 regulates TNF-alpha-induced matrix metalloproteinase-9 and tenascin expression in primary bronchial fibroblasts. J Immunol (2004) 0.89
Intrastriatal CERE-120 (AAV-Neurturin) protects striatal and cortical neurons and delays motor deficits in a transgenic mouse model of Huntington's disease. Neurobiol Dis (2008) 0.89
Gene delivery of Homer1c rescues spatial learning in a rodent model of cognitive aging. Neurobiol Aging (2013) 0.88
Later-onset congenital central hypoventilation syndrome due to a heterozygous 24-polyalanine repeat expansion mutation in the PHOX2B gene. Acta Paediatr (2008) 0.88
Monozygotic twins discordant for ROHHAD phenotype. Pediatrics (2011) 0.88
The significance of Pin1 in the development of Alzheimer's disease. J Alzheimers Dis (2007) 0.88
Upper cervical intramedullary spinal metastasis of ovarian carcinoma: a case report and review of the literature. J Med Case Rep (2011) 0.88
Sudden infant death syndrome: rare mutation in the serotonin system FEV gene. Pediatr Res (2007) 0.87
MPEP reduces seizure severity in Fmr-1 KO mice over expressing human Abeta. Int J Clin Exp Pathol (2009) 0.87
Effects of HNE-modification induced by Abeta on neprilysin expression and activity in SH-SY5Y cells. J Neurochem (2009) 0.87
Viral vectors for in vivo gene transfer in Parkinson's disease: properties and clinical grade production. Exp Neurol (2007) 0.86
Variable human phenotype associated with novel deletions of the PHOX2B gene. Pediatr Pulmonol (2011) 0.86
Facial phenotype in children and young adults with PHOX2B-determined congenital central hypoventilation syndrome: quantitative pattern of dysmorphology. Pediatr Res (2005) 0.85
Thymic stromal lymphopoietin (TSLP) as a bridge between infection and atopy. Int J Clin Exp Pathol (2008) 0.85
Pin1 protein regulates Smad protein signaling and pulmonary fibrosis. J Biol Chem (2012) 0.85